Resolved hyperthyroidism before IVF is not associated with improved cumulative live birth rates: a retrospective cohort study - Scorecard - MDSpire

Resolved hyperthyroidism before IVF is not associated with improved cumulative live birth rates: a retrospective cohort study

  • By

  • Huizi Jin

  • Jiejun Luo

  • Menglu Wu

  • Yuxuan Fang

  • Zijin Xu

  • Lin Zhu

  • Mingzhu Cao

  • Zhu Liang

  • Jing Wang

  • Yanshan Lin

  • Yixuan Wu

  • Wenju Peng

  • Haiying Liu

  • Jian-Qiao Liu

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Resolved Hyperthyroidism on Cumulative Live Birth Rates in IVF: Findings from a Retrospective Cohort Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsRemove unsupported claims and ensure it reflects findings from the study.
Target Population
Care Setting

Key Highlights

  • 0

Guideline-Based Recommendations

Diagnosis

  • A
  • t
  • t
  • r
  • i
  • b
  • u
  • t
  • e
  • t
  • o
  • s
  • p
  • e
  • c
  • i
  • f
  • i
  • c
  • g
  • u
  • i
  • d
  • e
  • l
  • i
  • n
  • e
  • s
  • o
  • r
  • s
  • t
  • u
  • d
  • i
  • e
  • s
  • .

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify source of insights.

        Clinical Best Practices

        • 0

        Related Resources & Content

        Original Source(s)

        Resolved hyperthyroidism before IVF is not associated with improved cumulative live birth rates: a retrospective cohort study

        • by Huizi Jin, Jiejun Luo, Menglu Wu, Yuxuan Fang, Zijin Xu, Lin Zhu, Mingzhu Cao, Zhu Liang, Jing Wang, Yanshan Lin, Yixuan Wu, Wenju Peng, Haiying Liu, Jian-Qiao Liu

        • June 2, 2026

        Related Content

        Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin

        Association between endogenous oxytocin levels and live birth rates following fresh embryo transfer: a prospective cohort study

        Dendrobine inhibits anaplastic thyroid cancer progression by targeting the JAK-STAT3 pathway